Jun Feng

Identification of CDKN1A as a Candidate Therapeutic Target in Peripheral Artery Disease Progression: Integrative Multi-omics and Mendelian Randomization Study.

INTRODUCTION Therapeutic strategies for advanced Peripheral Artery Disease (PAD), including angiogenic gene therapy trials, have yielded limited clinical benefit, partly because target selection has relied on empirical biological reasoning rather than genetic causal evidence. Since the progression from Intermittent Cla...